Annual CFF
$0.00
$0.000.00%
31 December 2023
Summary:
XTL Biopharmaceuticals annual cash flow from financing activities is currently $0.00, unchanged on 31 December 2023. During the last 3 years, it has risen by $0.00 (0.00%). XTLB annual CFF is now -100.00% below its all-time high of $24.46 million, reached on 31 December 2006.XTLB Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
N/A
31 March 2024
Summary:
XTL Biopharmaceuticals quarterly cash flow from financing activities is not available.XTLB Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
N/A
31 March 2024
Summary:
XTL Biopharmaceuticals TTM cash flow from financing activities is not available.XTLB TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XTLB Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | 0.0% | - | - |
| 3 y3 years | 0.0% | - | - |
| 5 y5 years | - | - | - |
XTLB Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | |||||
| 5 y | 5 years | -100.0% | |||||
| alltime | all time | -100.0% |
XTL Biopharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $0.00(0.0%) | - | - |
| Dec 2022 | $0.00(-100.0%) | - | - |
| Dec 2021 | $385.00 K(>+9900.0%) | - | - |
| Dec 2020 | $0.00(0.0%) | - | - |
| Dec 2019 | $0.00(-100.0%) | - | - |
| Dec 2017 | $4.89 M(>+9900.0%) | - | - |
| Dec 2016 | $0.00(-100.0%) | - | - |
| Dec 2015 | $3.58 M(+1058.3%) | - | - |
| Dec 2014 | $309.00 K(-2.5%) | $0.00(-100.0%) | $309.00 K(-35.8%) |
| Sept 2014 | - | $13.00 K(-80.3%) | $481.00 K(-19.2%) |
| June 2014 | - | $66.00 K(-71.3%) | $595.00 K(+10.6%) |
| Mar 2014 | - | $230.00 K(+33.7%) | $538.00 K(+69.7%) |
| Dec 2013 | $317.00 K(-92.6%) | $172.00 K(+35.4%) | $317.00 K(+39.6%) |
| Sept 2013 | - | $127.00 K(+1311.1%) | $227.00 K(-54.1%) |
| June 2013 | - | $9000.00(0.0%) | $495.00 K(-5.2%) |
| Mar 2013 | - | $9000.00(-89.0%) | $522.00 K(-87.8%) |
| Dec 2012 | $4.28 M | $82.00 K(-79.2%) | $4.28 M(+2.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | $395.00 K(+997.2%) | $4.20 M(+10.6%) |
| June 2012 | - | $36.00 K(-99.0%) | $3.80 M(+1.4%) |
| Mar 2012 | - | $3.77 M(>+9900.0%) | $3.75 M(+114.9%) |
| Dec 2011 | $1.74 M(>+9900.0%) | $0.00(-100.0%) | $1.74 M(0.0%) |
| Sept 2011 | - | -$7000.00(-53.3%) | $1.74 M(-45.9%) |
| June 2011 | - | -$15.00 K(-100.8%) | $3.22 M(-0.5%) |
| Mar 2011 | - | $1.77 M(+19.9%) | $3.24 M(+119.9%) |
| Sept 2010 | - | $1.47 M(>+9900.0%) | $1.47 M(>+9900.0%) |
| June 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2009 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2009 | - | $0.00 | $0.00 |
| Dec 2008 | $210.00 K(-97.6%) | - | - |
| Dec 2007 | $8.80 M(-64.0%) | - | - |
| Dec 2006 | $24.46 M(+1518.8%) | - | - |
| Dec 2005 | $1.51 M(-90.2%) | - | - |
| Dec 2004 | $15.45 M(>+9900.0%) | - | - |
| Dec 2003 | $4000.00 | - | - |
FAQ
- What is XTL Biopharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual CFF year-on-year change?
- What is the all time high quarterly CFF for XTL Biopharmaceuticals?
- What is the all time high TTM CFF for XTL Biopharmaceuticals?
What is XTL Biopharmaceuticals annual cash flow from financing activities?
The current annual CFF of XTLB is $0.00
What is the all time high annual CFF for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual cash flow from financing activities is $24.46 M
What is XTL Biopharmaceuticals annual CFF year-on-year change?
Over the past year, XTLB annual cash flow from financing activities has changed by $0.00 (0.00%)
What is the all time high quarterly CFF for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly cash flow from financing activities is $3.77 M
What is the all time high TTM CFF for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high TTM cash flow from financing activities is $4.28 M